| ID | 352 |
|---|
| No | 352 |
|---|
| Brand Name | LORLACARE |
|---|
| Ingredients | LORLATINIB 100 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON - SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON CRIZOTINIB AND AT LEAST ONE OTHER ALK INHIBITOR FOR METASTATIC DISEASE OR ALECTINIB AS THE FIRST ALK INHIBITOR THERAPY FOR METASTATIC OR CRITINIB AS THE FIRST ALK INHIBITOR THERAPY METASTATIC DISEASE |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0849/21 |
|---|
| FDD Registration Date | 07-AUG-2024 |
|---|
| Expiry Date | 06-AUG-2027 |
|---|
